Remove 2023 Remove Controlled Substances Remove Labelling
article thumbnail

Schedule III Marijuana Would Still Be Regulated Marijuana

The FDA Law Blog

Houck In August 2023, the U.S. Department of Health and Human Services (HHS), based on the federal Controlled Substances Acts (CSAs) Eight Factor Analysis, recommended that the Drug Enforcement Administration (DEA) reschedule marijuana from schedule I to schedule III. Schedules of Controlled Substances, 44,621.

article thumbnail

Medication Safety Quiz 2023

OctariusRx

The 2023 version of the OctariusRx medication safety quiz is about to be released. What does the Medication Safety Quiz 2023 cover and how do you get one? The quiz focuses on some of the most commonly encountered situations, including allergies, labeling medications and controlled substances.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

The FDA Law Blog

Palmer — The 2008 Ryan Haight Online Pharmacy Consumer Protection Act placed strict limits on online prescribing or the use of telemedicine encounters to prescribe controlled substances. That emergency declaration is set to expire on May 11, 2023. By Karla L. 21 U.S.C. §

article thumbnail

Can you take Vyvanse for weight loss?

The Checkup by Singlecare

In fact, the official FDA guidance about Vyvanse specifically warns against off-label use (a use that is not approved by the FDA) for weight loss, stating, “Vyvanse is not indicated or recommended for weight loss. These effects are more likely if you have a history of mental illness, substance [use disorder], or bipolar disorder.”

Labelling 125
article thumbnail

Vyvanse generic availability, cost, and dosage

The Checkup by Singlecare

It is a Drug Enforcement Administration (DEA) controlled substance in the Schedule II category. Non-amphetamine-based ADHD treatments, such as Strattera , are not controlled substances. Food and Drug Administration (FDA) in 2007 for treatment and symptom control in ADHD. Vyvanse was initially approved by the U.S.

Dosage 92
article thumbnail

DEA Regs Bulk Up with 2014 Anabolic Steroid Control Law Additions

The FDA Law Blog

Houck — Anabolic steroids that include testosterone, methyltestosterone, nandrolone decanoate and oxandrolone are schedule III controlled substances with currently accepted medical uses in the U.S. Implementation of the Designer Anabolic Steroid Control Act of 2014 , 88 Fed. By Larry K. 50,036 (Aug.

article thumbnail

OPDP Comes out Swinging With A Warning Letter on Unsubstantiated Efficacy

The FDA Law Blog

And before CooperSurgical, another 2021 Warning Letter was issued to AcelRx for the infamous “Tongue and Done” tagline used to promote a Schedule II controlled substance subject to a REMS program that requires a healthcare professional’s precise placement of the drug using a single-dose applicator into the patient’s sublingual space.

FDA 52